# Combination Osteogenic Therapy in Established Osteoporosis

> **NCT00018447** · PHASE2 · COMPLETED · sponsor: **US Department of Veterans Affairs**

## Conditions studied

- Osteoporosis, Post-Menopausal

## Interventions

- **DRUG:** PTH 1-34
- **DRUG:** MFPSR-fluoride

## Key facts

- **NCT ID:** NCT00018447
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-11
- **Primary completion:** —
- **Final completion:** 2003-10
- **Target enrollment:** — (—)
- **Last updated:** 2009-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00018447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00018447, "Combination Osteogenic Therapy in Established Osteoporosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00018447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*